1. R-Phycoerythrin Induces SGC-7901 Apoptosis by Arresting Cell Cycle at S Phase
   Huixin Tan et al, 2016, Marine Drugs CrossRef
2. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
   Jing Yang et al, 2018, Biomed Pharmacother CrossRef
3. Structural modification of oridonin via DAST induced rearrangement
   Dong-Dong Luo et al, 2018, RSC Adv. CrossRef
4. Oridonin induces growth inhibition and apoptosis in human gastric carcinoma cells by enhancement of p53 expression and function
   Enxu Bi et al, 2018, Braz J Med Biol Res CrossRef
5. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
   Weixiao An et al, 2019, Front. Pharmacol. CrossRef
6. Oridonin inhibits hypoxia-induced epithelial–mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer
   Kunlun Chen et al, 2019, Anti-Cancer Drugs CrossRef
7. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
   Zhifang Gui et al, 2017, Int J Oncol CrossRef
8. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.
   Hua Luo et al, 2019, Chin Med CrossRef
9. Mechanistic Pathways and Molecular Targets of Plant-Derived Anticancer ent-Kaurane Diterpenes
   Md. Shahid Sarwar et al, 2020, Biomolecules CrossRef
10. Oridonin inhibits the migration and epithelial-to-mesenchymal transition of small cell lung cancer cells by suppressing FAK-ERK1/2 signalling pathway.
    Linhao Xu et al, 2020, J Cell Mol Med CrossRef
11. Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells
    Ning Kang et al, 2020, Toxicology in Vitro CrossRef
12. Oridonin Suppresses Human Gastric Cancer Growth in Vitro and in Vivo via Inhibition of VEGF, Integrin β3, and PCNA
    Qiong Yang et al, 2020, Biological & Pharmaceutical Bulletin CrossRef
13. Oridonin induces apoptosis in HGC‑27 cells by activating the JNK signaling pathway
    Dong‑Lin Ren et al, 2019, Oncol Lett CrossRef
14. The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells
    Nor Isnida Ismail et al, 2020, Molecules CrossRef
15. Oridonin interrupts cellular bioenergetics to suppress glioma cell growth by down-regulating PCK2.
    Jianhu Lin et al, 2021, Phytother Res CrossRef
16. Natural products: A lead for drug discovery and development
    Bhawna Chopra et al, 2021, Phytotherapy Research CrossRef
17. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.
    Xiang Li et al, 2021, Front Pharmacol CrossRef
18. Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway in vitro
    Yuying Fan et al, 2021, Oncol Lett CrossRef
19. Phytochemicals and mitochondria: Therapeutic allies against gastric cancer
    Maoyuan Zhao et al, 2022, Phytomedicine CrossRef
20. Key Targets and Molecular Mechanisms of Active Volatile Components of Rabdosia rubescens in Gastric Cancer Cells
    Yanhui Hu et al, 2022, CAD CrossRef
21. Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer
    Fangyuan Zhou et al, 2023, J Exp Clin Cancer Res CrossRef
22. The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
    Mohamed J. Saadh et al, 2023, Environmental Research CrossRef
23. The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems
    Xiangyan Hu et al, 2024, CPB CrossRef
24. Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin
    Yilin Su et al, 2024, Front. Pharmacol. CrossRef
25. Rabdosia rubescens (Hemsl.) H. Hara: A Potent Anti-Tumor Herbal Remedy - Botany, Phytochemistry, and Clinical Breakthroughs
    Shiyong Gao et al, 2024, Journal of Ethnopharmacology CrossRef